Group A streptococcal vaccines: Paving a path for accelerated development
Highlights ► We summarize the global burden of group A streptococcal diseases. ► We review the current status of group A streptococcal vaccines. ► We describe obstacles to streptococcal vaccine development. ► We detail a path for accelerated vaccine development. ► Cooperation and collaboration are k...
Saved in:
Published in | Vaccine Vol. 31; pp. B216 - B222 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
18.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights ► We summarize the global burden of group A streptococcal diseases. ► We review the current status of group A streptococcal vaccines. ► We describe obstacles to streptococcal vaccine development. ► We detail a path for accelerated vaccine development. ► Cooperation and collaboration are keys to success. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.vaccine.2012.09.045 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 ObjectType-Feature-1 |
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2012.09.045 |